Baker Bros. Relentlessly Adding Shares Of One Biotech, Going Activist On Another
Julian Baker and Felix Baker’s Baker Bros. Advisors continues to relentlessly add shares to its position in Seattle Genetics, Inc. (NASDAQ:SGEN).
Dbv Technologies S.a. (DBVT)
Market is closed
News
- First
- << Previous
- 21 - 24
XenoPort, Inc. And DBV Technologies SA: Two Healthcare Stocks With Opposing Momentum
XenoPort, Inc. (NASDAQ:XNPT) saw its stock price surge by more than 7% in pre-market trading today, owing to the success of its XP23829 treatment in s mid-stage psoriasis study.
Baker Bros. Advisors Buys More DBV Technologies S.A. (DBVT); Visium Asset Management Goes Long On Pacira Pharmaceuticals Inc. (PCRX)
According to a freshly-amended 13G filing with the SEC, Baker Bros. Advisors LP, founded by Julian Baker and Felix Baker, revealed it owns 15.1% of DBV Technologies S.A.
Avalanche Biotechnologies Inc (AAVL), Anacor Pharmaceuticals Inc (ANAC), DBV Technologies, Boulogne-Billancourt (DBVT): Among Venrock's Top Succesful Biotech Plays
Venrock Healthcare Capital Partners is a fund that is focused entirely on the healthcare sector, mainly on the biotech sector.
- First
- << Previous
- 21 - 24
Billionaire Hedge Funds
